Abstract:Frontotemporal dementia (FTD) is a fatal neurodegenerative disease characterized by changes in social and emotional behavior. The disease can be caused by mutations in GRN that result in haploinsufficiency of the neuronal and microglial protein progranulin. Recent findings using Grn-/- mice have directed attention to progranulin's function in microglia and its contribution to neuroinflammation. Grn-/- mice have FTD-related behavioral deficits and gliosis similar to the human disease, however they do not model progranulin haploinsufficiency. We sought to determine the relative effects of progranulin insufficiency on neurons and microglia in mouse models. In this study we tested the behavior, physiology, neuropathology, inflammatory mediators, and neuronal morphology in Grn+/- mice at different ages to investigate the relationship between neuroinflammation and neuronal dysfunction in FTD. Grn+/- mice displayed FTD-related behavioral deficits, similar to Grn-/- mice, without neuroinflammation. We found reduced social behavior in Grn+/- and Grn-/- mice using the three-chamber sociability test. This social deficit was constant between multiple cohorts on two separate genetic backgrounds and appeared to be age-dependent, with deficits emerging after 4 months. In addition to the three-chamber test, we observed abnormal social behavior in Grn+/- mice using the tube test of social dominance. We also found emotional impairments in Grn+/- and Grn-/- mice, evident by decreased freezing in a classical fear-condition paradigm. Whereas social/emotion impairment was clear, we found no hippocampal-dependent behavioral or electrophysiological impairment in Grn+/- mice. This is consistent with the relative preservation of other cognitive domains early in FTD.Gliosis and increased TNF-Î ± mRNA levels were not observed in Grn+/- mice, unlike Grn-/- mice, demonstrating a dissociation of neuroinflammation and neuronal dysfunction. Therefore, we analyzed neuronal morphology and found that Grn+/- mice, as well as Grn-/- mice, displayed abnormal dendritic architecture in the amygdala, a region that controls social/emotional behavior and is implicated in FTD. Our results demonstrate that neuroinflammation and microglial involvement are not a driving force in FTD due to progranulin haploinsufficiency and suggest a vital role for progranulin in neurons. Also, Grn+/- mice are a useful tool in studying the behavioral deficits in FTD.

Suppression of Progranulin Expression Leads to Formation of Intranuclear TDP-43 Inclusions in Vitro: A Cell Model of Frontotemporal Lobar Degeneration

Establishment of A Stable Progranulin Deficient Cell Line: A Model of Frontotemporal Dementia with Ubiquitin-Positive Inclusions

Pathogenic cysteine mutations affect progranulin function and production of mature granulins.

An Alternative In Vitro Model Of Neurodegeneration In Ftld-U With Pgrn Mutation

FTLD-TDP with and Without GRN Mutations Cause Different Patterns of CA1 Pathology

Disease and Region Specificity of Granulin Immunopositivities in Alzheimer Disease and Frontotemporal Lobar Degeneration.

Induced Pluripotent Stem Cell Models of Progranulin-Deficient Frontotemporal Dementia Uncover Specific Reversible Neuronal Defects.

Frontotemporal Dementia Patient Neurons With Progranulin Deficiency Display Protein Dyshomeostasis

PGRN and frontotemporal lobar degeneration

Enhanced legumain activity links progranulin deficiency to TDP-43 pathology in frontotemporal lobar degeneration

Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency

Granulin loss of function in human mature brain organoids implicates astrocytes in TDP-43 pathology

Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia

Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA-binding protein 43 inclusions) in missense progranulin mutation Cys139Arg

Induced Pluripotent Stem Cell Models of Progranulin-Deficient Frontotemporal Dementia Uncover Specific Reversible Neuronal Defects

Progranulin Protects Against Amyloid Β Deposition and Toxicity in Alzheimer’s Disease Mouse Models

Progranulin haploinsufficiency mediates cytoplasmic TDP-43 aggregation with lysosomal abnormalities in human microglia

Exaggerated Inflammation, Impaired Host Defense, and Neuropathology in Progranulin-Deficient Mice

Ftd-Psp Is An Unusual Clinical Phenotype In A Frontotemporal Dementia Patient With A Novel Progranulin Mutation

Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration

Neuronal Effects of Progranulin Deficiency Contribute to Frontotemporal Dementia Independent of Neuroinflammation